ArticleDeutsches Arzteblatt international2017
Preventing Myopia.
Article in Deutsches Arzteblatt international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 15 citations in OpenAlex.
- MEMS Smart Glass with Larger Angular Tuning Range and 2D Actuation.Micromachines · 2024Article
- Behavioural determinants of physiologically-relevant light exposure.Communications psychology · 2024Review
- Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder.International journal of bipolar disorders · 2023Article
- Current Insights into Optimal Lighting for Promoting Sleep and Circadian Health: Brighter Days and the Importance of Sunlight in the Built Environment.Nature and science of sleep · 2022Review
- A Three-Dimensional-reconstruction-based study on the ocular volume of Chinese children with high myopia.BMC ophthalmology · 2021Article
- Recommendations for progressive myopia in childhood and adolescence : Statement of the German Society of Ophthalmology (DOG) and the Professional Association of German Ophthalmologists (BVA). Status December 2018.Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020Review
- [Multimodal diagnostic of CSNB1 with NYX gene mutation].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019Article
- A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia.Ophthalmology and therapy · 2019Article
- [Recommendations for progressive myopia in childhood and adolescence : Statement of the German Society of Ophthalmology (DOG) and the Professional Association of German Ophthalmologists (BVA). Status December 2018].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019Article
- Reading and Myopia: Contrast Polarity Matters.Scientific reports · 2018Article
- Myopia prevalence and risk factors among medical trainees in Lebanon.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological SocietyArticle
- Myopia Controlling using Low Dose Atropine Eye Drop.Journal of current ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNearsightedness (myopia) has become more common around the world recently, mainly because of changes in visual, educational, and recreational behavior. The question arises how the risk of myopia and its progression can be reduced. This would lessen the prevalence and severity of myopia and also lower the risk of secondary diseases that impair visual acuity.
methodsThe PubMed/Medline database was selectively searched for pertinent literature.
resultsThe risk of myopia is lowered by exposure to daylight and increased by activities performed at short visual distances (close-up work). A person with little exposure to daylight has a fivefold risk of developing myopia, which can rise as high as a 16-fold risk if that person also performs close-up work. Two meta-analyses and a large randomized clinical trial from Asia have shown that the progression of myopia over two years of observation can be lessened by up to 0.71 diopters by the administration of atropine eye drops in a concentration that has practically no serious side effects. At higher doses, myopia progresses more severely than in the placebo group after the cessation of therapy. This is an off-label treatment. A weaker effect on progression has been shown for multifocal optical corrections that include both a distance correction and a correction for near vision.
conclusionEffective pharmacological and optical measures are now available to lessen the progression of myopia. The increasing prevalence of myopia should motivate pediatricians, parents, and schools to pay attention to risk factors such as close-up work and lack of daylight exposure, particularly in view of the increased use of digital media.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.